Filed before 2025Filed 16 November 2022
Haystack Oncology, Inc. raised $67M
Haystack Oncology, Inc., a biotech company based in Baltimore, MD, raised $67M in a new equity round, according to a filing dated 16 November 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 16 November 2022
- Round
- Equity round
- Amount sold
- $67M
- Offering size
- $67M
- Investors so far
- 6
- Based in
- Baltimore, MD
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 91% of the 1,764 tracked raises with an amount filed in 2022, and than 87% of the 142 in biotech.
Haystack Oncology, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 16 Nov 2022 | New filing | $67M | This raise |
More with Catalio Nexus on the board
- Iambic Therapeutics, Inc.$66M
- NextPoint Therapeutics, Inc.$33.7M
- ManaT Bio, Inc.$72.1M
- eNeura, INC.$511K
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.